WATCH: RFK Jr. says FDA will remove long-standing warning from hormone-based menopause drugs
Summary
The FDA announced the removal of a bold warning label from hormone-based drugs used for menopause symptoms. This decision reflects updated evidence suggesting fewer risks when therapy starts before age 60 or within ten years of menopause. Some experts support this change, but others call for a more careful review process.Key Facts
- The FDA will remove the bold warning labels from hormone-based menopause drugs.
- These drugs treat symptoms like hot flashes, night sweats, and involve hormones estrogen and progestin.
- The old warning highlighted risks of stroke, heart attack, and dementia.
- The FDA's decision is based on studies showing fewer risks when therapy starts early.
- Health Secretary Robert F. Kennedy Jr. supports the change for a more evidence-based approach.
- Some doctors and pharmaceutical companies support the label change, arguing it's outdated.
- Critics argue for a transparent process involving independent advisers before changing the label.
- Research in the past linked hormone drugs to higher risks of health issues, leading to the original warning.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.